Topamax is used to treat several different types of seizures alone and in combination with other seizure medicines.

Topamax is approved by the Food and Drug Administration (FDA) for:

• partial-onset seizures in adults and children ages 2-16 years
• generalized tonic-clonic seizures in adults and children ages 2-16 years
• seizures associated with Lennox-Gastaut syndrome in people 2 years of age and older

Topamax is approved by the Food and Drug Administration (FDA) as initial monotherapy for patients 10 years of age and older with partial-onset or primary generalized tonic-clonic seizures.

Partial seizures are seizures that begin in a limited area of the brain. Sometimes these seizures spread throughout the brain.

Generalized seizures begin throughout the brain.

Topamax is also effective for other childhood epilepsies.

Continue on to How Does Topomax Affect the Brain?